Skip to main content
. 2014 Jun 25;3:10.3402/jev.v3.23784. doi: 10.3402/jev.v3.23784

Table I.

Effect of cavin-1 expression on proteins in PC3 EVs with reported roles in bone metastasis

Accession Protein name Mean ratio (cavin-1:GFP) No. of Obs p
Decreased in cavin-1 EVs
P05231 Interleukin-6 0.1011 28 0.0063
Q13253 Noggin 0.1575 2 0.00414
P12110 Collagen alpha-2(VI) chain 0.262 3 0.00618
P08476 Inhibin beta A chain 0.2396 30 0.00683
P17936 Insulin-like growth factor-binding protein 3 0.3655 2 0.03129
P12109 Collagen alpha-1(VI) chain 0.4159 62 0.01493
P08195 4F2 cell-surface antigen heavy chain 0.4424 14 0.01487
P00749 Urokinase-type plasminogen activator 0.4494 139 0.03151
P29317 Ephrin type-A receptor 2 0.527 11 0.02467
P04080 Cystatin-B 0.5346 27 0.0169
P02751 Fibronectin 0.567 4 0.14112
P61812 Transforming growth factor beta-2 0.5858 55 0.01978
Increased in cavin-1 EVs
P18065 Insulin-like growth factor-binding protein 2 3.9048 4 0.00605
P00750 Tissue-type plasminogen activator 2.0035 6 0.03213
No change in cavin-1 EVs
Q15828 Cystatin-M 0.63017 6 0.23465
O94907 Dickkopf-related protein 1 0.73475 8 0.58905
Q02809 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 0.79309 22 0.80976
P01034 Cystatin-C 0.82386 22 0.87766
O00469 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 1.02675 4 0.97971

EVs were collected from stable isotopically labelled cells (SILAC) and analysed by LC–MS/MS (see (18) for details). SILAC ratios (cavin-1:GFP) provide an accurate relative quantitation of the 2 samples and p-value indicates significance. Primary data were published as Supplementary table in (18).